The heart in the stable COPD patient

Clinical Management of Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2002, Pages 475-532

  Lee Chiong, Teofilo L ^a   Matthay, Richard A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038505577     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (328)

1. Wiedemann HP, Matthay RA. Cor pulmonale in chronic obstructive pulmonary disease. Circulatory pathophysiology and management. Clin Chest Med 1990; 11:523–545.
2. Matthay RA, Niederman MS, Wiedemann HP. Cardiovascular-pulmonary interaction in chronic obstructive pulmonary disease with special reference to the pathogenesis and management of cor pulmonale. Med Clin North Am 1990; 74:571–618.
3. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest 1991; 99:715–723.
4. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one. Am J Respir Crit Care Med 1994; 150:833–852.
5. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am J Respir Crit Care Med 1994; 150:1158–1168.
6. Wiedemann HP, Matthay RA. Cor pulmonale. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine, 5th ed. Philadelphia: WB Saunders, 1997: 1604–1625.
7. Adnot S, Samoyeau R, Weitzenblum E. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Blood Press 1995; 3:47–57.
8. World Health Organization. Chronic cor pulmonale. A report of the expert committee. Circulation 1963; 27:594–598.
9. Vogt P, Ruttner JR. Das Cor pulmonale aus pathologisch-anatomischer Sicht. Schweiz Med Wochenschr 1977; 107:549–553.
10. Heath D, Brewer D, Hicken P. Mechanisms and pathology. In: Thomas CC, ed. Cor Pulmonale in Emphysema. Springfield, IL: CC Thomas, 1968:1–37.
11. Ben Jrad I, Slimane ML, Boujnah MR, Ben Hamda K, Ameur Y. Prognosis and treatment of chronic cor pulmonale. Tunis Med 1993; 71:505–508.
12. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996; 46:77–79.
13. Sliwinski P, Hawrylkiewicz I, Cieslicki J, Tobiasz M, Zielinski J. Value of additional qualifying tests for home oxygen therapy in patients with chronic obstructive diseases and moderate hypoxemia. Pol Tyg Lek 1993; 48:154–156.
14. Kuriyama T. Clinical aspects of precapillary pulmonary hypertension. (Nihon Kyobu Shikkan Gakkai Zasshi) Jpn J Thorac Dis 1992; 30:3–11.
15. Parameshwar J, Poole-Wilson PA, Sutton GC. Heart failure in a district general hospital. J R Coll Physicians Lond 1992; 26:139–142.
16. Mitchell RS, Vincent TN, Filley GF. Chronic obstructive bronchopulmonary disease. IV. The clinical and physiological differential of chronic bronchitis and emphysema. Am J Med Sci 1964; 247:513–517.
17. Renzetti AD Jr., McClement JH, Litt BD. The Veterans Administration cooperative study of pulmonary function. III. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966; 41:115–119.
18. Heath D, Du Shane JW, Wood EH, Edwards JE. Structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis. J Pathol Bacteriol 1959; 77:443–456.
19. Weibel ER, Gomez DM. The architecture of the human lung. Science 1962; 137:577–585.
20. Harris P, Heath D. Normal variations in pressure and flow. In: Harris P, Heath D, eds. The Human Pulmonary Circulation, 3rd ed. Edinburgh: Churchill Livingstone, 1986: 149–160.
21. Robin ED, Gaudio R. Cor pulmonale. DM 1970; May:1–38.
22. Niederman MS, Matthay RA. Cardiovascular function in secondary pulmonary hypertension. Heart Lung 1986; 15:341–351.
23. Burton AC. Relation of structure to function of tissues of walls of blood vessels. Physiol Res 1954; 34:619–623.
24. Lamb D. Pathology of COPD. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory Medicine. London: Bailliere Tindall, 1990:497–507.
25. Dunnill MS. Fibrinoid necrosis in the branches of the pulmonary artery and chronic non-specific lung disease. Br J Dis Chest 1960; 54:355–360.
26. Wilkinson M, Langhorne CA, Heath D, Barer GR, Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988; 66:65–85.
27. Bignion J, Khoury F, Even P, Andre J, Brouet G. Morphometric study in chronic obstructive broncho-pulmonary disease. Pathologic, clinical and physiologic correlations. Am Rev Respir Dis 1969; 99:669–695.
28. Harris P, Heath D. The pulmonary vasculature in emphysema. In: Harris P, Heath D, eds. The Human Pulmonary Circulation. Edinburgh: Churchill Livingstone, 1986:507–521.
29. Calverley PM, Howatson R, Flenley DC, Lamb D. Clinicopathological correlations in cor pulmonale. Thorax 1992; 47:494–498.
30. Riley RL, Himmelstein A, Morley HL, Motley HL, Weiner HM, Cournand A. Studies of the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. Am J Physiol 1948; 152:372–382.
31. Mounsey JPD, Ritzman LW, Selverstone NH, Briscoe WA, McLemore GA. Circulatory changes in severe pulmonary emphysema. Br Heart J 1952; 14:153–172.
32. Zhang ZX. The clinical investigation of the pulmonary arterial pressure in stable-stage chronic obstructive pulmonary disease with cor pulmonale. (Chung-Hua Chieh Ho Ho His Tsa Chih) Chin J Tuberc Respir Dis 1991; 14:353–355, 377.
33. Keller CA, Shepard JW Jr., Chun DS, Vasquez P, Dolan GF. Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis. Chest 1986; 90:185–192.
34. Naeije R. Should pulmonary hypertension be treated in chronic obstructive pulmonary disease? In: Weir EK, Archer SL, Reeves JT, eds. The Diagnosis and Treatment of Pulmonary Hypertension. New York: Futura Publishing, 1992:209–239.
35. McFadden ER, Braunwald E. Cor pulmonale. In: Braunwald E, ed. Heart Disease, 4th ed. Philadelphia: W.B. Saunders Company, 1992:1581–1601.
36. Furey SA, Zieska HA, Levy MN. The essential function of the right ventricle. Am Heart J 1984; 107:404–410.
37. Laks MM, Garner D, Swan HJC. Volumes and compliances measured simultaneously in the right and left ventricles of the dog. Circ Res 1967; 20:565–569.
38. Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 1980:453–471.
39. Khaja F, Parker JO. Right and left ventricular performance in chronic obstructive lung disease. Am Heart J 1971; 82:319–327.
40. MacNee W, Wathen CG, Hannan WJ, Flenley DC, Muir AL. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale. Br Med J 1983; 287:1169–1172.
41. MacNee W. Right ventricular function in cor pulmonale. Cardiology 1988; 75(Suppl 1):30–40.
42. Biernacki W, Flenley DC, Muir AL, MacNee W. Pulmonary hypertension and right ventricular function in patients with COPD. Chest 1988; 94:1169–1175.
43. Nahrendorf W, Hofs R, Gunkel H, Rosenkranz J. Contractility parameters of the right heart in patients with chronic obstructive lung diseases without pulmonary hypertension. Z Gesamte Inn Med 1987; 42:354–359.
44. Matthay RA, Arroliga AC, Wiedemann HP, Schulman DS, Mahler DA. Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease. Chest 1992; 101(Suppl 5):225S–262S.
45. Lavine SJ, Tami L, Jawad I. Pattern of left ventricular diastolic filling associated with right ventricular enlargement. Am J Cardiol 1987; 62:444–448.
46. MacNee W, Xue QF, Hannan WJ, Flenley DC, Adie CJ, Muir AL. Assessment by radionuclide angiography of right and left ventricular function in chronic bronchitis and emphysema. Thorax 1983; 38:494–500.
47. Mizushige K, Morita H, Senda S, Matsuo H. Influence of right ventricular pressure overload on left and right ventricular filling in cor pulmonale assessed with Doppler echocardiography. Jpn Circ J 1989; 53:1287–1296.
48. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113:576–583.
49. Jamal K, Fleetham JA, Thurlbeck WM. Cor pulmonale: correlation with central airway lesions, peripheral airway lesions, emphysema, and control of breathing. Am Rev Respir Dis 1990; 141:1172–1177.
50. Kohama A, Tanouchi J, Masatsugu H, Kitabatake A, Kamada T. Pathologic involvement of the left ventricle in chronic cor pulmonale. Chest 1990; 98:794–800.
51. Berry B, Wright JL. Long-term pulmonary hypertension produced by cigarette smoking is associated with subendocardial fibrosis and inflammation of the right ventricle: a morphometric analysis in the guinea pig model. Exp Pathol 1991; 43:163–172.
52. Minami H, Matsumoto H, Nagane T, Takeda A, Yahara O, Nakano H, Yamazaki Y, Osanai S, Akiba Y, Kikuchi K. Myocardial structural proteins in cor pulmonale. Analysis by two-dimensional electrophoresis. (Nihon Kyobu Shikkan Gakkai Zasshi) Jpn J Thorac Dis 1995; 33:599–604.
53. Abel RL. Effects of alterations in peripheral resistance on left ventricular function. Proc Soc Exp Biol Med 1965; 120:52–56.
54. Davies H, Overy HR. Left ventricular function in cor pulmonale. Chest 1970; 58:8–14.
55. Murphy ML, Adamson J, Hutcheson F. Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med 1974; 81:307–313.
56. Bove AA, Santamore WP. Ventricular interdependence. Prog Cardiovasc Dis 1981; 23:365–388.
57. Gupta S, Khastgir T, Gupta MP, Sethi KK, Manoharan S. Clinical, haemodynamic and echocardiographic study in chronic cor pulmonale. J Assoc Physicians India 1989; 37:373–376.
58. Zhang HY, Qiu HG, Wong XZ. Relation between oxygen consumption and oxygen delivery in chronic obstructive pulmonary diseases and chronic cor pulmonale. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1990; 29:597–599, 637.
59. Michaelson N. Bilateral ventricular hypertrophy due to chronic pulmonary disease. Dis Chest 1960; 38:435–446.
60. Fluck DC, Chandrasekar RG, Gardner FV. Left ventricular hypertrophy in chronic bronchitis. Br Heart J 1966; 28:92–97.
61. MacNee W, Morgan AD, Wathen CG, Muir AL, Flenley DC. Right ventricular performance during exercise in chronic obstructive pulmonary disease. Respiration 1985; 48:206–211.
62. Robotham JL, Lixfeld W, Holland L, MacGregor D, Bryan AC, Rabson J. Effects of respiration on cardiac performance. J Appl Physiol 1978; 44:703–709.
63. Weidemann HP, Matthay RA. Acute right heart failure. Crit Care Clin 1985; 1:571–578.
64. Von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 1946; 12:301–320.
65. Harvey RM, Ferrer MI, Richards DW, Cournand A. Influence of chronic pulmonary disease on the heart and circulation. Am J Med 1951; 10:719–738.
66. Enson Y, Guintini C, Lewis ML, Morris TQ, Ferrer MI, Harvey RM. The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation. J Clin Invest 1964; 43:1146–1162.
67. Harris P, Segel N, Green J, Housley E. The influence of the airways resistance and alveolar pressure on the pulmonary vascular resistance in chronic bronchitis. Cardiovasc Res 1968; 2:84–94.
68. Durand J, Leroy-Ladurie M, Ransom-Bitker B. Effects of hypoxia and hypercapnia on the repartition of pulmonary blood flow in supine subjects. Prog Respir Res 1970; 5:156–165.
69. Jin WY. Clinical study on hemodynamics, blood gases and hemorheologic monitoring of patients with cor pulmonale. (Chung His I Chieh Ho Tsa Chih) Chin J Modern Dev Tradit Med 1989; 9:522–525.
70. Levi-Valensi P, Weitzenblum E, Rida Z, Aubry P, Braghiroli A, Donner C, Aprill M, Zielinski J, Wurtemberger G. Sleep-related oxygen desaturation and daytime pulmonary hemodynamics in COPD patients. Eur Respir J 1992; 5:301–307.
71. Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76:536–542.
72. Midgren B, White T, Petersson K, Bryhn M, Airikkala P, Elmqvist D. Nocturnal hypoxaemia and cor pulmonale in severe chronic lung disease. Bull Eur Physiopathol Respir 1985; 21:527–533.
73. Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 1989; 95:157–166.
74. Ferrer MI. Cor pulmonale: present day status. Am Heart J 1975; 89:657–664.
75. Fowler NO. Chronic cor pulmonale. In: Fowler NO, ed. Diagnosis of Heart Disease. New York: Springer-Verlag, 1991:268–282.
76. Hicken P, Brewer D, Heath D. The relation between the weight of the right ventricle of the heart and the internal surface area and the number of alveoli in the human lung in emphysema. J Pathol Bacteriol 1966; 92:529–546.
77. Biernacki W, Gould GA, Whyte KF, Flenley DC. Pulmonary hemodynamics, gas exchange and the severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema. Am Rev Respir Dis 1989; 139:1509–1515.
78. Harris P, Segel N, Green J, Housley E. The influence of the airways resistance and alveolar pressure on the pulmonary resistance in chronic bronchitis. Cardiovasc Res 1968; 2:84–94.
79. Herzog H, Kopp C, Perruchoud A. Prevention and therapy of chronic cor pulmonale. Klin Wochenschr 1977; 55:777–786.
80. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine nitric oxide. Nature 1990; 345:167–173.
81. Rubanyi GM, Romero JC, Van Houtte PM. Flow induced release of endotheliumderived relaxing factor. Am J Physiol 1986; 250:1105–1149.
82. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilatation. J Clin Invest 1986; 78:1–5.
83. Moncada S, Palmer RMJ, Higgs EA. Prostacyclin and endothelial-derived relaxing factor: biological interactions and significance. In: Verstraete M, Verrmylen J, Lijnen RH, eds. Thrombosis and Haemostasis. Belgium: University Press Leuven, 1987:597–618.
84. Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996; 28:591–596.
85. Dinh-Xuan AT, Higenbottam TW, Wallwork J. Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology 1992; 43:350–356.
86. Cargill RI, Kiely DG, Clark RA, Lipworth BJ. Hypoxaemia and release of endothelin-1. Thorax 1995; 50:1308–1310.
87. Reffestin B, Valette H, Herbert JL, Duhaze P, Lockhart A. Pulmonary blood volume in chronic bronchitis. Clin Sci Mol Med 1977; 53:587–593.
88. Segel N, Bishop JM. The circulation in patients with chronic bronchitis and emphysema at rest and during exercise with special reference to the influence of change in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest 1966; 45:1555–1568.
89. Schuren KP, Huttemann U. Red cell mass and plasma volume in chronic cor pulmonale. Klin Wochenschr 1975; 53:823–829.
90. Evers H. Course study of pulmonary artery pressure in patients with chronic obstructive bronchitis. Z Erkr Atmungsorgane 1985; 164:67–73.
91. Weitzenblum E, Sautejeau A, Ehrhart M, Mammosser M, Pettetier A. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130:993–998.
92. Bishop JM, Cross KW. Use of other physiological variables to predict pulmonary arterial pressure in patients with chronic respiratory disease: multicenter study. Eur Heart J 1981; 2:509–517.
93. Bishop JM, Cross KW. Physiological variables and mortality in patients with various categories of chronic respiratory disease: WHO multicenter study. Bull Eur Physiopathol Respir 1984; 20:495–500.
94. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681–686.
95. Schrijen F, Uffholtz H, Polu JM, Poincelot F. Pulmonary and systemic hemodynamic evaluation in chronic bronchitis. Am Rev Respir Dis 1978; 117:25–31.
96. Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinjanahary J. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 1979; 75:656–662.
97. Weitzenblum E, Mammosser M, Ehrhart M. Evolution and prognosis of pulmonary hypertension in chronic obstructive pulmonary diseases. Herz 1986; 11:147–154.
98. Oswald-Mammoser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995; 107:1193–1198.
99. Burrows B, Fletcher CM, Heard BE, Jones NL, Woatliff JS. Clinical types of chronic obstructive lung disease in London and in Chicago: a study of 100 patients. Am Rev Respir Dis 1964; 90:14–27.
100. Weitzenblum E, Hirth C, Duculone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36:752–758.
101. Finlay M, Middleton HC, Peake MD, Howard P. Cardiac output, pulmonary hypertension, hypoxaemia and survival in patients with chronic obstructive airways disease. Eur J Respir Dis 1983; 64:252–263.
102. Langloh P, Brandli O, Schnieper R. Probability of survival and prognostic factors in chronic obstructive lung disease. Schweiz Med Wochenschr 1982; 112:1841–1846.
103. Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, Tartoni PL. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration 1994; 61:8–13.
104. France AJ, Prescott RJ, Biernacki W, Muir AL, MacNee W. Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax 1988; 43:621–626.
105. Miyagi S, Irei M, Matsumoto T, Jinno S. New trends in home oxygen therapy (HOT) after the introduction of health insurance coverage in Okinawa and factors contributing to long-term survival. (Nihon Kyobu Shikkan Gakkai Zasshi) Jpn J Thorac Dis 1989; 27:404–410.
106. MacNee W. Predictors of survival in patients treated with long-term oxygen therapy. Respiration 1992; 59(Suppl 2):5–7.
107. Conte G, Lauro S, Lazzarin M, Rigon N, Perrone A. Evaluation of hyperkinetic cardiac arrhythmia in chronic obstructive bronchopneumopathy. Minerva Cardioangiol 1997; 45:429–433.
108. Kleiger RE, Senior RM. Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 1974; 65:483–487.
109. Holford FD, Mithoefer JC. Cardiac arrhythmias in hospitalized patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1973; 108:879–885.
110. Sideris DA, Katsadoros DP, Valianos G, Assioura A. Type of cardiac dysrhythmias in respiratory failure. Am Heart J 1975; 89:32–35.
111. Kirby BJ, McNicol MW, Tattersfield AE. Arrhythmias, digitalis and respiratory failure. Br J Dis Chest 1970; 64:212–219.
112. Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99:1415–1420.
113. Levine JH, Michael JR, Guarnieri T. Multifocal atrial tachycardia: a toxic effect of theophylline. Lancet 1985; 1:12–14.
114. Banner AS, Sunderrajan EV, Agarwal MK, Addington WW. Arrhythmogenic effects of orally administered bronchodilators. Arch Intern Med 1979; 139:434–437.
115. Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med 1998; 243:361–366.
116. Bradshear RE. Arrhythmias in patients with chronic obstructive pulmonary disease. Med Clin North Am 1984; 68:969–981.
117. Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC. Disturbances of rhythm in chronic lung disease. Heart Lung 1977; 6:256–261.
118. Hudson LD, Kurt TL, Petty TL, Genton E. Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. Chest 1973; 63:661–665.
119. Gulsvik A, Hansteen V, Sivertssen E. Cardiac arrhythmias in patients with serious pulmonary diseases. Scand J Resp Dis 1978; 59:154–159.
120. Semple PA, Watson WS, Beastall GH, Hume R. Endocrine and metabolic studies in unstable cor pulmonale. Thorax 1983; 38:45–49.
121. Kinasewitz GT, Groome JL, Marchall RP, Leslie WK, Diana JN. Effect of hypoxia on permeability of pulmonary endothelium of canine visceral pleura. J Appl Physiol 1986; 61:554–560.
122. Heath D, Williams DR. Man at High Altitude. Edinburgh: Churchill Livingstone, 1981.
123. De Bold AJ, Borenstein HB, Veressa AT, Jonnerberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89–94.
124. Yamaji T, Ishibishi M, Takaku F. Atrial natriuretic factor in human blood. Clin Invest Med 1985; 76:1705–1709.
125. Burnett JC, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984; 247:863–866.
126. Sagnelia GA, Markandu ND, Shore AC, MacGregor GA. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 1985; 2:1208–1210.
127. Anderson JV, Donckier J, Payne NN, Beacham J, Slater JD, Bloom SR. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci 1987; 72:305–312.
128. Burghuber OC, Hartter E, Punzengruber C, Weissel M, Woloszczuk W. Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis. Chest 1988; 92:31–37.
129. Winter RJD, Davidson AC, Treacher D, Rudd RM, Anderson JV, Meleagros L, Bloom SR. Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to hemodynamic and blood gas variables and response to supplemental oxygen. Thorax 1989; 44:58–62.
130. Mannix ET, Dowdeswell I, Carlone S, Palnge P, Aronoff GR, Farber MO. The effect of oxygen on sodium excretion in hypoxaemic patients with obstructive lung disease. Chest 1990; 97:840–844.
131. Skwarski K, Lee M, Turnbull L, MacNee W. Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease. Thorax 1993; 48:730–735.
132. Adnot S, Chabrier PE, Andrivet P, Viossat I, Piquet J, Brun-Buisson C, Gutkowska Y, Braquet P. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis 1987; 136:951–956.
133. Stewart AG, Bardsley PA, Baudouin SV, Waterhouse JC, Thompson JS, Morice AH, Howard P. Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale. Thorax 1991; 46:829–834.
134. Cargill RI, Lipworth BJ. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects. Chest 1996; 110:1220–1225.
135. Anand IS, Chandrashekhar Y, Ferrari R, Sarma S, Guleria R, Tindal SK, Purshotam LW, Poole-Wilson P, Harris P. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Circulation 1992; 86:12–21.
136. Watanabe E, Ogawa K, Ban M, Satake T. Sympathetic nervous systems in chronic cor pulmonale. Jpn Circ J 1981; 45:646–653.
137. Skwarski K, Morrison D, Sime P, Lee M, MacNee W. Effects of hypoxia on hormonal balance in chronic obstructive lung disease (COLD). Thorax 1993; 48:446.
138. Gould AB, Goodman SA. The effect of hypoxia on the renin-angiotensinogen system. Lab Invest 1970; 22:443–447.
139. Liang CS, Cavras H. Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia: effects of systemic hemodynamics, regional blood flows, and tissue metabolism. J Clin Invest 1978; 62:961–970.
140. Weismann DN, Williamson HE. Hypoxaemia increases renin secretion rate in anaesthetised newborn lambs. Life Sci 1981; 29:1887–1893.
141. Raff H, Fagin KD. Measurement of hormones and blood gases during hypoxia in conscious cannulated rats. J Appl Physiol 1984; 56:1426–1430.
142. Farber MO, Kiblawi SSO, Strawbridge RA, Robertson GL, Weinberger MH, Manfredi F. Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease. J Lab Clin Med 1977; 90:373–380.
143. Reihman DH, Farber MO, Weinberger MH, Henry DP, Fineberg NS, Dowdeswell IRG, Burt RW, Manfredi F. Effect of hypoxemia on sodium and water excretion in chronic obstructive lung disease. Am J Med 1985; 78:87–94.
144. Raff H, Levy SA. Renin-angiotensin-aldosterone and ACTH-cortisol control during hypoxemia and exercise in patients with chronic obstructive lung disease. Am Rev Respir Dis 1986; 133:369–399.
145. Cargill RI, Lipworth BJ. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 1995; 40:11–18.
146. Guan SB. Changes of angiotensin II and angiotensin-converting enzyme in cor pulmonale with respiratory failure. (Chung-Hua I Hsueh Tsa Chih) Chin Med J 1989; 69: 200–202.
147. Oswald M, Weitzenblum E. Pulmonary artery hypertension in chronic respiratory diseases. Rev Prat 1991; 41:1548–1553.
148. Grandberg P. Effect of acute hypoxia on renal haemodynamics and water diuresis in man. Scand J Clin Lab Invest 1962; 14:5–62.
149. Aber GM, Bayley TJ, Bishop JM. Inter-relationships between renal and cardiac function and respiratory gas exchange in obstructive airways disease. Clin Sci 1963; 25: 159–170.
150. Farber MO, Bright TP, Strawbridge RA, Robertson GL, Manfredi F. Impaired water handling in chronic obstructive lung disease. J Lab Clin Med 1975; 85:41–49.
151. Farber MO, Roberts LR, Weinberger MH, Robertson GL, Manfredi F. Abnormalities of sodium and H2O handling of chronic obstructive lung disease. Arch Intern Med 1982; 142:1326–1330.
152. Sun ZL, Zhang HX, Xu Z. Effect of respiratory failure on water and sodium metabolism. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1989; 28:343–346.
153. Campbell JL, Calverley PM, Lamb D, Flenley DC. The renal glomerulus in hypoxic cor pulmonale. Thorax 1982; 37:607–611.
154. Baudouin SV, Bott J, Ward A, Deane C, Moxham J. Short-term effect of oxygen on renal haemodynamics in patients with hypoxaemic chronic obstructive airways disease. Thorax 1992; 47:550–554.
155. Howes TQ, Deane CR, Levin GE, Baudouin SV, Moxham J. The effects of oxygen and dopamine on renal and aortic blood flow in chronic obstructive pulmonary disease with hypoxemia and hypercapnia. Am J Respir Crit Care Med 1995; 151:378–383.
156. Anderson RJ, Pluss RG, Berns AS, Jackson JT, Arnold PE, Schrier RW, McDonald KM. Mechanism of effect of hypoxia on renal water excretion. J Clin Invest 1978; 62:769–777.
157. Sherman S. Cor pulmonale. Treatment implications of right versus left ventricular impairment. Postgrad Med 1992; 91:227–236.
158. Morpurgo M. Non-invasive assessment of pulmonary arterial hypertension in chronic lung disease (WHO study). Eur Respir J 1989; 2:666S–668S.
159. Hill NS. The cardiac exam in lung disease. Clin Chest Med 1987; 8:273–285.
160. Lehtonen J, Sutinen S, Ikaheimo P, Paakko P. Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy. Chest 1988; 93:839–842.
161. Kilcoyne MM, Davis AL, Ferrer MI. A dynamic electrocardiographic concept useful in the diagnosis of cor pulmonale. 1970; 42:903.
162. Sarubbi B, Esposito V, Ducceschi V, Meoli I, Grella E, Santangelo L, Iacano A, Caputi M. Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy? Int J Cardiol 1997; 58:287–292.
163. Srivastava P, Mittal SR, Srivastava N. Role of oesophageal electrocardiograms in differentiation of old anteroseptal myocardial infarction from emphysema in cases with poor R wave progression in precordial leads. J Assoc Physicians India 1991; 39:249–250.
164. Tatum VD, Light RW. Approach to the diagnosis of secondary pulmonary hypertension: the chest roentgenogram as a diagnostic tool. Heart Lung 1986; 15:352–357.
165. Matthay RA, Schwarz MI, Ellis JH, Steele PP, Siebert PE, Durrance JR, Levin DC. Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 1981; 16:95–100.
166. Chetty K, Brown SE, Light RW. Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiograph. Am Rev Respir Dis 1982; 126:338–341.
167. Himelman RB, Struve SN, Brown JK, Namnum P, Schiller NB. Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am J Med 1988; 84:891–898.
168. Berger HJ, Matthay RA. Noninvasive radiographic assessment of cardiovascular function in acute and chronic respiratory failure. Am J Cardiol 1981; 47:950–962.
169. Matthay RA, Berger HJ. Non-invasive assessment of right and left ventricular function in acute and chronic respiratory failure. Crit Care Med 1983; 11:329–338.
170. Stevenson G, Kawabori I, Guntheroth W. The validation of doppler diagnosis of tricuspid regurgitation. Circulation 1981; 64(Suppl 4):255.
171. Himelman RB, Stulbarg K, Kircher B, Lee E, Kee M, Dean NK, Golden J, Wolfe CL, Schiller NB. Non-invasive evaluation of pulmonary arterial pressure during exercise by saline enhanced doppler echocardiography in chronic pulmonary disease. Circulation 1989; 79:863–871.
172. Weitzenblum E, Zielinski J, Bishop JM. The diagnosis of “cor pulmonale” by noninvasive methods: a challenge for pulmonologists and cardiologists. Bull Eur Physiopathol Respir 1983; 19:423–426.
173. Bommer W, Weinert L, Neumann A, Neef J, Mason DT, DeMaria A. Determination of right atrial and right ventricular size by two-dimensional echocardiography. Circulation 1979; 60:91–100.
174. Starling MR, Crawford MH, Sorensen SG, O’Rourke RA. Two-dimensional echocardiographic technique evaluating right ventricular size and performance in patients with obstructive lung disease. Circulation 1982; 66:612–620.
175. Berger HJ, Matthay RA, Loke J, Marshal RC, Gottschalk A, Zaret BL. Assessment of cardiac performance with quantitative radionuclide angiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. Am J Cardiol 1978; 41:897–905.
176. Maddahi J, Bermon DS, Matsuoka DT, Waxman AD, Stankus KE, Forrester JS, Swan HJ. A new technique for assessing right ventricular ejection fraction using rapid multiple gated equilibrium cardiac blood pool scintigraphy. Circulation 1979; 60:581–589.
177. Wu WQ. Measurement of right and left heart function of COPD and cor pulmonale by radionuclide ventriculography. (Chung-Hua Chieh Ho Ho Hu His Tsa Chih) Chin J Tuberc Respir Dis 1992; 15:149–152.
178. Berger HJ, Matthay RA, Davies RA, Zaret BL, Gottschalk A. Comparison of exercise right ventricular performance in chronic obstructive pulmonary disease and coronary artery disease: non-invasive assessment by quantitative radionuclide angiocardiography. Invest Radiol 1979; 14:342–353.
179. Matthay RA, Berger HJ. Cardiovascular performance in chronic obstructive pulmonary disease. Med Clin North Am 1981; 65:489–520.
180. MacNee W, Morgan AD, Wathen CG, Muir AL, Flenley DC. Right ventricular performance during exercise in chronic obstructive pulmonary disease. Respiration 1985; 48:206–211.
181. Wolf JE, Fagret D, Godart J, Comet M, Paramelle B. Measurement of right ventricular ejection fraction with krypton-81m in chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir 1986; 22:539–544.
182. Kato H, Misawa T, Kutsumi Y, Sasaki F, Ishizaki T, Nakai T, Miyabo S, Matsushita T, Nakajima T, Ishii Y. Quantitative evaluation of right ventricular overload in cor pulmonale using 201T1 myocardial SPECT. J Cardiology 1990; 20:167–175.
183. Longmore DB, Klipstein RH, Underwood SR, Firmin DN, Hounsefield GN, Watanabe M, Bland C, Fox K, Poole-Wilson PA, Rees RSO, Denison D, Burman ED. Dimensional accuracy of magnetic resonance studies of the heart. Lancet 1985; 1:1360–1362.
184. Turnbull LW, Ridgeway JP, Biernacki W, McRitchie H, Muir AL, Best JJK, MacNee W. Assessment of the right ventricle by magnetic resonance imaging in chronic obstructive lung disease. Thorax 1990; 45:597–601.
185. Pattynama PMT, Willems LNA, Smit AH, van der Wall EE, de Roos A. Early diagnosis of cor pulmonale with MR imaging of the right ventricle Radiology 1992; 182: 375–379.
186. British Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating bronchitis and emphysema. Lancet 1981; 1:681–685.
187. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93:391–398.
188. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102:29–36.
189. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 131:493–498.
190. Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest 1975; 68:486–492.
191. Leggett RJ, Cooke NJ, Clancy L, Leitch AG, Kirby BJ, Flenley DC. Long-term domiciliary oxygen therapy in cor pulmonale complicating chronic bronchitis and emphysema. Thorax 1976; 31:414–418.
192. Gluskowski J, Jedrzejewska-Makowska M, Hawrylkiewicz I, Vertun B, Zielinski J. Effects of prolonged oxygen therapy on pulmonary hypertension and blood viscosity in patients with advanced cor pulmonale. Respiration 1983; 44:177–183.
193. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long-term domiciliary oxygen therapy. Thorax 1987; 42: 105–110.
194. Wu WQ. Measurement of right and left heart function of COPD and cor pulmonale by radionuclide ventriculography. (Chung-Hua Chieh Ho Ho His Tsa Chih) Chin J Tuberc Respir Dis 1992; 15:149–152.
195. Morrison DA, Henry R, Goldman S. Preliminary study of the effects of low flow oxygen on oxygen delivery and right ventricular function in chronic obstructive lung disease. Am Rev Respir Dis 1986; 133:390–395.
196. Wiedemann HP, Matthay RA. Cor pulmonale in chronic obstructive pulmonary disease: Circulatory pathophysiology and new concepts of therapy. In: Simmons DH, ed. Current Pulmonology, Vol. 8. Chicago: Year Book Medical Publishers, 1987:127–162.
197. Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance. Chest 1990; 97:706–718.
198. Ferlinz J. Right ventricular diastolic performance: Compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade. Cathet Cardiovasc Diagn 1998; 43:206–243.
199. Olvey SK, Reduto LA, Stevens PM, Deaton WJ, Miller RR. First-pass radionuclide assessment of right and left ventricular ejection fraction in chronic pulmonary disease: Effect of oxygen upon exercise response. Chest 1980; 78:4–9.
200. Anthonisen NR. Long-term oxygen therapy. Ann Intern Med 1983; 99:519–527.
201. Flenley DC, Muir AL. Cardiovascular effects of oxygen therapy for pulmonary arterial hypertension. Clin Chest Med 1983; 4:297–308.
202. Weidemann HP, Matthay RA. Management of cor pulmonale. In: Scharf SM, Cassidy SS, eds. Heart-Lung Interactions in Health and Disease. New York: Marcel Dekker, 1989:915–981.
203. Sroczynski J, Podolecki A, Koczwara A, Biskupek K, Burak W, Schneiberg P. Longterm oxygen therapy of chronic pulmonary heart disease. Pneumonol Pol 1990; 58: 8–11.
204. Klein G, Matthys H. Acute and long-term effects of chronic obstructive lung diseases. Pneumologie 1990; 44(Suppl 1):188–190.
205. Ashutosh K, Mead G, Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis 1983; 127:399–404.
206. Geraads A, Levy P, Brambilla C, Paramelle B. Desaturation and nocturnal pulmonary arterial hypertension in C.O.P.D.: effects of oxygen therapy. Rev Mal Respir 1984; 1:319–325.
207. Ching-Chi L. Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD. Am J Respir Crit Care Med 1996; 154:353–358.
208. MacNee W, Wathen CG, Flenley DC, Muir AD. The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale. Am Rev Respir Dis 1988; 137:1289–1295.
209. Doherty JE, Kane JJ, Phillips JR, Adamson JS. Digitalis in pulmonary heart disease (cor pulmonale). Drugs 1977; 13:142–151.
210. Orlov VA, Zavolovskaia LI, Barkhanova AG, Romanenko AM. The efficacy of lanikor in treating patients with chronic cor pulmonale. Klin Med Mosk 1990; 68:64–65.
211. Berglund E, Widimsky J, Malmberg R. Lack of effect of digitalis in patients with pulmonary disease with and without heart failure. Am J Cardiol 1963; 11:477–482.
212. Green LH, Smith TW. The use of digitalis in patients with pulmonary disease. Ann Intern Med 1977; 87:459–465.
213. Jezek V, Schrijen F. Hemodynamic effect of deslanoside at rest and during exercise in patients with chronic bronchitis. Br Heart J 1973; 35:2–8.
214. Mathur PN, Powles P, Pugsley SO, McEwan MP, Campbell EJ. Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial. Ann Intern Med 1981; 95:283–288.
215. Polic S, Rumboldt Z, Dujic Z, Bagatin J, Deletis O, Rozga A. Role of digoxin in right ventricular failure due to chronic cor pulmonale. Int J Clin Pharmacol Res 1990; 10: 153–162.
216. Mathur PN, Powles AC, Pugsley SO, McEwan MP, Campbell EJ. Effect of long-term administration of digoxin on exercise performance in chronic airflow limitation. Eur J Respir Dis 1985; 66:273–283.
217. Kim YS, Aviado DM. Digitalis and the pulmonary circulation. Am Heart J 1961; 62: 680–686.
218. Bracchi G, Vezzoli F, Ronchi B, Longhini E. Indications and limits in the use of digitalis in chronic cor pulmonale. G Ital Cardiol 1975; 5:216–232.
219. Green LH, Smith TW. The use of digitalis in patients with pulmonary diseases. Ann Intern Med 1977; 87:459–465.
220. Heinman HO. Right-sided heart failure and the use of diuretics. Am J Med 1978; 64: 357–370.
221. Howard P. Vasodilator drugs in chronic obstructive airways disease. Eur Respir J 1989; 7:678S–681S.
222. Chen YT, Chen KS, Chen JS, Lin WW, Hu WH, Chang MK, Lee DY, Lee YS, Lin JR, Chiang BN. Aortic and pulmonary input impedance in patients with cor pulmonale. Jpn Heart J 1990; 31:619–629.
223. Saadjian A, Philip-Joet F, Tran N’guyen A, Arnaud A, Torresani J. Nifedipine in the treatment of chronic cor pulmonale. Arch Mal Coeur Vaiss 1986; 79:76–83.
224. Saadjian A, Philip-Joet F, Arnaud A. Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease. Cardiology 1987; 74:196–204.
225. Sturani C, Bassein L, Schiavina M, Gunella G. Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). Chest 1983; 84:135–142.
226. Morley TF, Zappasodi SJ, Belli A, Giudice JC. Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale. Treatment with nifedipine, nitroglycerin, and oxygen. Chest 1987; 92:71–76.
227. Singh H, Ebejer MJ, Higgins DA, Henderson AH, Campbell IA. Acute hemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale. Thorax 1985; 40:910–914.
228. Mookherjee S, Ashutosh K, Dunsky M, Hill N, Vardan S, Smulyan H, Warner R. Nifedipine in chronic cor pulmonale: acute and relatively long-term effects. Clin Pharmacol Ther 1988; 44:289–296.
229. Vestri R, Philip-Joet F, Surpas P, Arnaud A, Saadjian A. One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease. Respiration 1988; 54:139–144.
230. Wu WQ, Rong ZS, Yang XQ. Hemodynamic studies of pulmonary heart diseases and the effects of nifedipine. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1994; 33: 21–23.
231. Shan ZY. Effects of verapamil on pulmonary arterial pressure in patients with cor pulmonale complicated by heart failure. (Chung-Hua Chieh Ho Ho His Tsa Chih) Chin J Tuberc Respir Dis 1989; 12:340–342.
232. Kakhnovskii IM, Sivkov SI, Markova ZS, Ivanova IL, Sivkov AS. The possibilities of isoptin treatment of pulmonary hypertension in patients with chronic obstructive bronchitis. Klin Med Mosk 1997; 75:48–52.
233. Bujak K, Kozik T. Effect of single dose administration of nitrendipine on pulmonary arterial pressure measured using doppler echocardiography. Pneumonol Alergol Pol 1995; 63:298–303.
234. Rubin LJ, Moser K. Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale. Chest 1986; 89:141–145.
235. Bratel T, Hedenstierna G, Lundquist H, Nyquist O, Ripe E. Cardiac function and central haemodynamics in severe chronic obstructive lung disease. Acute and long-term effects of felodipine. Eur Respir J 1988; 1:262–268.
236. Butorov IV, Matkovskii SK, Butorova VG. Nifangin in the combined treatment of chronic cor pulmonale. Vrach Delo 1990; 11:24–27.
237. Konietzko N, Schlehe H, Harich B, Matthys H. Effect of isosorbide dinitrate on hemodynamics and respiration of patients with coronary artery disease and of patients with chronic cor pulmonale. Respiration 1975; 32:368–377.
238. MacNee W, Walthen CG, Hannan WJ, Flenley DC, Muir AL. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale. Br Med J 1983; 287:1169–1172.
239. Bai CX, Xiu SF, Xu FP. The changes in blood gases, hemodynamics and oxygen delivery after weaning and the treatment of sodium nitroprusside in mechanically ventilated patients with cor pulmonale. (Chung-Hua Chieh Ho Ho Hu His Tsa Chih) Chin J Tuberc Respir Dis 1993; 16:335–337, 373.
240. Wang HY, Zhang HY, Weng XZ. Hemodynamics changes in patients with chronic cor pulmonale secondary to COPD and effect of sodium nitroprusside administration. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1991; 30:141–143.
241. Tuxen DV, Powles ACP, Mathur PN, Pugsley SO, Campbell EJ. Detrimental effects of hydralazine in patients with chronic airflow obstruction and pulmonary hypertension. A controlled hemodynamic and radionuclide study. Am Rev Respir Dis 1984; 129:388–395.
242. Rubin LJ, Peter RH. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. Am J Cardiol 1981; 47:116–122.
243. Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL. Contrasting acute effects of vasodilators (nitroglycerine, nitroprusside and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study. Am J Cardiol 1983; 51: 1682–1689.
244. Keller CA, Shepard JW, Chun DS, Dolan GF, Vasquez P, Minh V-D. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 1984; 130:606–611.
245. Rubin LJ, Handel F, Peter RH. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure. Circulation 1982; 65: 1369–1373.
246. Miller MJ, Chappell TR, Cook W, De Olazabal JR, Rubin LJ. Effects of oral hydralazine on gas exchange in patients with cor pulmonale. Am J Med 1983; 75:937–942.
247. Dal Nogare AR, Rubin LJ. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:385–389.
248. Brent BN, Matthay RA, Mahler DA, Berger HJ, Zaret BL, Lister G. Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease. Physiologic effects of nitroprusside and hydralazine. Am Rev Respir Dis 1984; 129:682–686.
249. Lupi-Herrera E, Seoane M, Verdejo J. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise. Chest 1984; 85:156–163.
250. McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J 1983; 50:579–585.
251. Cargill RI, Lipworth BJ. Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed. Pulm Pharmacol 1994; 7:305–310.
252. Takada K, Hayashi M, Takahashi K, Yasui S. Acute effects of oral captopril on hemodynamics in patients with cor pulmonale. Jpn Circ J 1986; 50:1055–1061.
253. Tang B, Cheng Z, Huang Y. A research of acute hemodynamics and hormonal changes of intravenous captopril in patients with cor pulmonale and pulmonary hypertension. (Chung-Hua Chieh Ho Ho His Tsa Chih) Chin J Tuberc Respir Dis 1995; 18:303–305.
254. Burke CM, Harte M, Duncan J, Connolly HM, Horgan JH, Theodore J, Callaghan B. Captopril and domiciliary oxygen in chronic airflow obstruction. Br Med J 1985; 290: 1251.
255. Zielinski J, Hawrylkiewicz I, Gorecka D, Gluskowski J, Koscinska M. Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Chest 1986; 90:562–565.
256. Lewczuk J, Wrabec K, Piszko P, Jagas J, Porada A, Reczuch K, Spikowsli J. Enalapril improves hemodynamics and exercise tolerance in pulmonary heart disease caused by obstructive lung disease. Kardiol Pol 1992; 37:3–7.
257. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997; 33:201–208.
258. Borkenstein J. Decrease in arterial PO2 with captopril administration in secondary pulmonary hypertension and right heart failure. Wiener Medizin Wochensch 1987; 137:332–334.
259. Li T, Lei Y, Huang S, Zhang M, Zhang Y, Zhou Q, Xian Q. Observation on TXB2 and 6-keto-PGF1 alpha in serum of patients with cor pulmonale. Hua-Hsi i Ko Ta Hsueh Hsueh Pao 1996; 27:320–322.
260. Mei XW, Du BY, Weng XZ. The interaction of some active and immunological factors in blood in the development of chronic cor pulmonale. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1992; 31:157–159.
261. Packer M. Vasodilator therapy for primary pulmonary hypertension. Ann Intern Med 1985; 103:258–270.
262. Naeije R, Melot C, Mols P, Hallemans R. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease. Am Rev Respir Dis 1982; 125:1–5.
263. Guo ZH, Ye YQ, Jing BW. Effects of different dosage of PGE1 in pulmonary arterial hypertension. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1993; 32:591–593.
264. 1 derivative. Effects of oral administration to patients with chronic lung disease. Chest 1984; 85:382–386.
265. Jones K, Higgenbottam T, Wallwork J. Pulmonary vasodilation and prostacyclin in primary and secondary pulmonary hypertension. Chest 1989; 96:784–789.
266. Parker JO, Kelkar K, West RO. Hemodynamic effects of aminophylline in cor pulmonale. Circulation 1966; 33:17–25.
267. Jezek V, Ourednik A, Stepanek J, Boudik F. The effect of aminophylline on the respiration and pulmonary circulation. Clin Sci 1970; 38:549–554.
268. Matthay RA. Favorable cardiovascular effects of theophylline in COPD. Chest 1987; 92:22S–26S.
269. Matthay RA. Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease. Chest 1985; 88(Suppl):112S–117S.
270. Matthay RA, Berger HJ, Davies R, Gottschalk A, Zaret BL. Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease. Am Heart J 1982; 104:1022–1026.
271. Matthay RA, Mahler DA. Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease. J Allergy Clin Immunol 1986; 78:793–799.
272. Matthay RA, Berger HJ, Loke J, Gottschalk A, Zaret BL. Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography. Am J Med 1978; 65:903–910.
273. Trembath PW, Boobis SW, Richens A. Theophylline: biochemical pharmacology and pharmacokinetics. J Int Med Res 1979; 7(Suppl 1):4–15.
274. Dal Negro R, Turco P, Pomari C, Monici-Preti P. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation. Int J Clin Pharmacol Ther Toxicol 1987; 25:401–405.
275. Vicuna N, McNay JL, Ludden TM, Schwertner H. Impaired theophylline clearance in patients with cor pulmonale. Br J Clin Pharmacol 1979; 7:33–37.
276. Hendeles L, Weinberger M. Avoidance of adverse effects during chronic therapy with theophylline. Eur J Respir Dis 1980; 109:103–119.
277. Matthay RA, Matthay MA, Weinberger MM. Grand mal seizure induced by oral theophylline. Thorax 1976; 31:470–471.
278. Stockley RA, Finnegan P, Bishop JM. Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax 1977; 32:601–605.
279. Chan CK, Loke J, Snyder PE, Wackers F, Mattera J, Matthay RA. Oral terbutaline augments cardiac performance in chronic obstructive pulmonary disease. Am J Med Sci 1988; 296:33–38.
280. Tschopp JM, Gabathuler J, Righetti A, Junod AF. Comparative effects of acute O2 breathing and terbutaline in patients with chronic obstructive pulmonary disease. A combined hemodynamic and radionuclide study. Eur J Respir Dis 1985; 67:351–359.
281. 2-agonist, in chronic cor pulmonale. J Cardiovasc Pharmacol 1987; 9:129–134.
282. Mols P, Ham H, Naeije N, Dechamps P, Huynh CH, Vandenbosch L, Serysels R. How does salbutamol improve the ventricular performance in patients with chronic obstructive pulmonary disease? J Cardiovasc Pharmacol 1988; 12:127–133.
283. Biernacki W, Prince K, Whyte K, MacNee W, Flenley DC. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy. Am Rev Respir Dis 1989; 139:492–497.
284. Gould L, Zahir M, DeMartino A, Gomprecht RF. Haemodynamic effects of phentolamine in chronic obstructive pulmonary disease. Br Heart J 1971; 33:445–450.
285. Whyte KF, Flenley DC. Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema? Thorax 1988; 43:1–8.
286. VanMieghem W, De Backer G, De Wispelaere B, Billiet L, Cosemans J. Phentolamine infusion in cor pulmonale due to chronic obstructive pulmonary disease. Acta Cardiol 1978; 33:253–262.
287. Vik-Mo H, Walde N, Jentoft H, Halvorsen FJ. Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale. Eur Heart J 1985; 6:1047–1053.
288. Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F. Hemodynamic effects of urapidil in patients with pulmonary hypertension: a comparative study with hydralazine. Am Rev Respir Dis 1987; 135:288–293.
289. Adnot S, Andrivet P, Piquet J, Brun-Buisson C, Rauss A, Bignon J, Lemaire F. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis 1988; 137:1068–1074.
290. Bardsley PA, Tweney J, Morgan N, Howard P. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. Thorax 1991; 46:493–498.
291. Evans TW, Tweney J, Waterhouse JC, Nichol J, Suggett AJ, Howard P. Almitrine bismesylate and oxygen therapy in hypoxic cor pulmonale. Thorax 1990; 45:16–21.
292. Chardon P, Prefaut C, Kienlen J, Griffe O, du Cailar J. Effects of almitrine on the pulmonary circulation. Ann Anesthesiol Franc 1980; 21:525–529.
293. Bell RC, Mullins RC, West LG, Bachand RT, Johanson WG Jr. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease. Ann Intern Med 1986; 105:342–346.
294. Tellier P, Voisin C. Almitrine dimesylate: deductions and therapeutic prospects. Presse Med 1984; 13:2099–2103.
295. Tellier P. Originality of the mode of action of almitrine dimesylate. Presse Med 1984; 13:2083–2089.
296. Arnaud F, Bertrand A, Charpin J, Chretein J, Decroix G, Guerrin F, Kalb JC, Lissac J, Michel FB, Morere P, et al. Long-term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study. Eur J Respir Dis 1983; 126:323–336.
297. Melot C, Naeije R, Rothschild T, Mertens P, Mols P, Hallemans R. Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 1983; 83:528–533.
298. Powles AC, Tuxen DV, Mahood CB, Pugsley SO, Campbell EJ. The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction. Am Rev Respir Dis 1983; 127:284–289.
299. Romaldini H, Rodriguez-Roisin R, Wagner PD, West JB. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog. Am Rev Respir Dis 1983; 128: 288–293.
300. Connaughton JJ, Douglas NJ, Morgan AD, Shapiro CM, Critchley JA, Pauly N, Flenley DC. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema. Am Rev Respir Dis 1985; 132:206–210.
301. Maxwell DL, Cover D, Hughes JMB. Almitrine increases the steady-state hypoxic ventilatory response in hypoxic chronic air-flow obstruction. Am Rev Respir Dis 1985; 132:1233–1237.
302. Escourrou P, Simonneau G, Ansquer JC, Duroux P, Lockhart A. A single orally administered dose of almitrine improves pulmonary gas exchange during exercise in patients with chronic airflow obstruction. Am Rev Respir Dis 1986; 133:562–567.
303. MacNee W, Connaughton JJ, Rhind GB, Hayhurst MD, Douglas NJ, Muir AL, Flenley DC. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. Am Rev Respir Dis 1986; 134:559–565.
304. Watanabe S, Kanner RE, Cutillo AG, Menlove RL, Bachand RT Jr, Szalkowski MB, Renzetti AD Jr. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:1269–1273.
305. Bai CX, Niu SF, Zhang HX. The effects of sodium nitroprusside and almitrine bismesylate on blood gases, hemodynamics and oxygen delivery in patients with cor pulmonale. (Chung-Hua Nei Ko Tsa Chih) Chin J Intern Med 1993; 32:388–391.
306. Van Mieghem W, Van den Brande P, De Waele R, Meirghaeghe J, Arens M, Demedts M. Evaluation of the safety and efficacy of amrinone in chronic obstructive lung disease with cor pulmonale. Acta Cardiol 1990; 1:57–64.
307. Wang C. Hemodynamic effects of amrinone on cardiopulmonary decompensated chronic cor pulmonale. (Chung-Hua I Hsueh Tsa Chih) Chin Med J 1992; 72:553–555.
308. Evans TW, Waterhouse J, Finlay M, Suggett AJ, Howard P. The effects of long-term methyldopa in patients with hypoxic cor pulmonale. Br J Dis Chest 1988; 82:405–413.
309. Howes TQ, Deane CR, Levin GE, Baudouin SV, Moxham J. The effects of oxygen and dopamine on renal and aortic blood flow in chronic obstructive pulmonary disease with hypoxemia and hypercapnia. Am J Res Crit Care Med 1995; 151:378–383.
310. Chan TYK. Low-dose dopamine in severe right heart failure and chronic obstructive pulmonary disease. Ann Pharmacother 1995; 29:493–496.
311. Segal N, Bishop JM. The circulation in patients with chronic bronchitis and emphy sema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest 1966; 45:1555–1568.
312. Dayton LM, McCullough RE, Scheinhorn DJ, Weil JV. Symptomatic and pulmonary response to acute phlebotomy in secondary polycythemia. Chest 1975; 68:785–790.
313. Weisse AB, Mochos CB, Frank MJ, Levinson GE, Canilla JE, Regan TJ. Hemodynamic effect of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels. Am J Med 1975; 58:92–98.
314. Chetty KG, Brown SE, Light RW. Improved exercise tolerance of the polycythemic lung patient following phlebotomy. Am J Med 1983; 74:415–420.
315. Thiele G, Burkmann I, Ziesenhenn K, Herold B. Isovolemic hemodilution—an adjuvant treatment principle in patients with chronic cor pulmonale caused by chronic obstructive lung disease. Z Gesamte Inn Med 1990; 45:315–318.
316. Wallis PJ, Skehan JD, Newland AC, Wedzicha JA, Mills PG, Empey DW. Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythemia and cor pulmonale. Clin Sci 1986; 70:91–98.
317. Milne N, Light RW, Chetty KG. Exercise-induced changes in left ventricular function after phlebotomy in patients with polycythemic COPD. J Thorac Imaging 1990; 5:68–72.
318. Chetty KG, Light RW, Stansbury DW, Milne N. Exercise performance of polycythemic chronic obstructive pulmonary disease patients. Effect of phlebotomies. Chest 1990; 98:1073–1077.
319. Germann P, Ziesche R, Leitner C, Roeder G, Urak G, Zimpfer M, Sladen R. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Chest 1998; 114:29–35.
320. Howes TQ, Keilty SE, Maskrey VL, Deane CR, Baudouin SV, Moxham J. Effect of L-arginine on renal blood flow in normal subjects and patients with hypoxic chronic obstructive pulmonary disease. Thorax 1996; 51:516–519.
321. Rubin LJ. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension. Clin Chest Med 1983; 4:309–319.
322. Rubin LJ. Vasodilators and pulmonary hypertension: Where do we go from here? Am Rev Respir Dis 1987; 135:288–293.
323. Guyton AC ed. Textbook of Medical Physiology. 6th ed. Philadelphia: WB Saunders, 1981.
324. McFadden ER, Braunwald E. Cor pulmonale and pulmonary thromboembolism. In Braunwald E ed. Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1980.
325. Berger HJ, Matthay RA, Loke J, Marshal RC, Gottschalk A, Zaret BL. Assessment of cardiac performance with quantitative radionuclide angiography: Right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. Am J Cardiol 1978; 41:897–905.
326. Rudolph AM, Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest 1966; 45:399–411.
327. Matthay RA, Berger HJ, Davies RA, Loke J, Mahler DA, Gottschalk A, Zaret BL. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: Radionuclide assessment. Ann Intern Med 1980; 93:234–239.
328. Brent BN, Mahler D, Berger HJ, Matthay RA, Pytlik L, Zaret BL. Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: A combined radionuclide and hemodynamic study. Am J Cardiol 1982; 50:313–319.